 |
|
|
| |
Comparison of HIV-1 Intermittent Viremia for Two Drug (DTG+RPV) vs Three Drug Current Antiretroviral Therapy in the SWORD-1 and SWORD-2 Studies
|
| |
| |
Reported by Jules Levin
HIV Drug Therapy, Glasgow 2018, October 28-31, 2018, Glasgow
Ruolan Wang,1Mark Underwood,1Justin Koteff,1Kostas Angelis,2Brian Wynne,1Veerle Van Eygen,3Elizabeth Blair,1Lesley Kahl,4Tia Vincent,4Michael Aboud4
1ViiV Healthcare, Research Triangle Park, NC, USA; 2GlaxoSmithKline,Stockley Park West, UK; 3Janssen Pharmaceutica, Beerse, Belgium; 4ViiV Healthcare, Brentford, UK
|
| |
|
|
|
|
|
